2003 Volume 2 Issue 2 Pages 21-28
Most existing researches treated pharmaceutical product development process as a sort of “black box." This paper, however, will focus on the product development process to explore the organizational capabilities and effective development patterns. Interviews and statistical analyses with leading companies in Japanese pharmaceutical industry indicated that “go or no-go decision" is the significant organizational capability, in fact differing among companies, which effects performances in pharmaceutical product development process. This organizational capability is accumulated through experiences in pharmaceutical product development projects.